the Effect of Different Drugs and Infusion Ways on Degree of Postoperative Comfort

NCT04111328 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2021-02-09

No results posted yet for this study

Summary

To explore the effect of different drugs and infusion ways on degree of postoperative comfort.Patients undergoing spinal neoplasm surgery receive different patient controlled analgesia(PCA) drugs postoperatively,one group is sufentanil,the other is hydromorphone. Then each drug group will be divided into two subgroups according to the infusion way,intravenously,subcutaneously. During the patient controlled analgesia period, patients' degree of comfort,pain score,sleep quality, the degree of side reaction will be recorded.

Conditions

  • Analgesia, Patient-Controlled

Interventions

DRUG

intravenous sufentanil

The PCA pumps contain sufentanil . And the pump is connected to participants intravenously .

DRUG

subcutaneous sufentanil

The PCA pumps contain sufentanil. And the pump is connected to participants subcutaneously.

DRUG

intravenous hydromorphone

The PCA pumps contain hydromorphone. And the pump is connected to participants intravenously .

DRUG

subcutaneous hydromorphone

The PCA pumps contain hydromorphone. And the pump is connected to participants subcutaneously.

DRUG

intravenous sufentanil and dexmedetomidine

The PCA pumps contain sufentanil and dexmedetomidine. And the pump is connected to participants intravenously .

DRUG

subcutaneous sufentanil and dexmedetomidine

The PCA pumps contain sufentanil and dexmedetomidine. And the pump is connected to participants subcutaneously.

DRUG

intravenous hydromorphone and dexmedetomidine

The PCA pumps contain hydromorphone and dexmedetomidine. And the pump is connected to participants intravenously.

DRUG

subcutaneous hydromorphone and dexmedetomidine

The PCA pumps contain hydromorphone and dexmedetomidine. And the pump is connected to participants subcutaneously

Sponsors & Collaborators

  • Jun Wang

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-08
Primary Completion
2020-09-30
Completion
2020-10-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04111328 on ClinicalTrials.gov